2024 ISMRM Call for Late-Breaking Abstracts

We invite late-breaking abstracts in response to the 2023-2024 Clinical Translation:  Unmet Needs Challenge.  The purpose of this challenge is to identify specific Unmet Clinical Needs, and communicate these to members so that they may focus research toward high-impact problems.  Abstracts will be judged specifically on how they address one of the six Unmet Needs on the challenge website, with up to ten finalists accepted for presentation during the 1:30-3:30pm session on Tuesday May 7 at the 2024 ISMRM meeting.

You may submit a revision to an abstract that was submitted to the scientific program, or you may submit a completely new abstract.  Both will be considered for the challenge ONLY (not for the scientific program).  Alternatively, you may simply point to an abstract that you submitted in November, regardless of whether it was accepted, and it will additionally be considered for the challenge.  Note that you MUST ADDITIONALLY submit the information on the challenge form, located here: https://challenge.ismrm.org/2023-24-clinical-translation-challenge/entry-form/

All information is posted on the Challenge website.  Late breaking abstracts are submitted using the same format as scientific abstracts with two modifications.  First, as the category, you will select the unmet need to which you are responding, and second, your abstract should specifically state how you are responsive to the unmet need.

In March, we will also re-launch this challenge for 2024-25, with a call for new Unmet Clinical Needs.

Submission Guidelines

Note: These format guidelines are the same as for regular scientific session abstracts submitted in November 2023.

What’s New for 2024?

Our abstract submission continually evolves to adapt to changing science, and to efficiently organize and present information.  A few changes for 2024 to look for:

1. Optional fields for authors to add pronouns and/or phonetic pronunciation of names.
2. Structured Synopsis and Impact sections replace the prior synopsis and 250 character summary.
3. A simplified preview figure is requested for the program (not used in abstract review).
4. The word limit for the main abstract body is 750 words.

Synopsis & Impact

Each abstract is accompanied by a 100-word synopsis and 40-word impact statement. These should be written in simple, clear language, at a higher level than the main abstract, to be broadly understandable to members who may not be in your direct field. The synopsis and impact must include text only, without equations or images, and be without references or citations to items described in the full abstract. We suggest the use of abstract keywords in the synopsis to improve the searchability of your abstract after publication.

You may notice that the format for the synopsis and impact is slightly different this year, using structured sections. The goal of the change was to help convey to the community not only a synopsis of the science of the project, but the potential impact in a more specific way than in prior years.

Why this emphasis? We all pursue research in order to have an impact. But in the day to day work, and especially as we come together as a group to exchange our research results, it’s easy to lose sight of the specific end goal. So we’re bringing it back in explicitly. We want to convey to each other what motivated our projects, what we did, and why it will matter. Not only will this enhance our conversations together, thinking this way will help in any networking situation, framing manuscripts and proposals, and design of future studies for impact.

The synopsis should be entered in the following sections, with a 100-word limit applied to total of the 4 sections:

• Motivation: State specifically what motivates the research study, for example what new knowledge is being sought, what specific step in a clinical problem your research is addressing, and/or for what reason some technical development is needed. Try to avoid broad statements such as “early detection of x disease is important.”
• Goal(s): The goal of this particular study. What specific question is being asked, what technical goal or specific advancement in capability is being sought?
• Approach: The overall approach taken to address the goal, such as the study design to test a hypothesis or type of methodology to advance imaging tools. May include animal model, clinical trial, technology development, or other.
• Results: Core results of the study that show how well you achieved the goals. Note that the “Impact” section will appear below the synopsis when printed, so you do not need to duplicate text from the “Impact” section here.

An additional 40-word Impact section will follow and complete the synopsis in the abstract, but will also appear alone in the poster teaser slides and program. Therefore it should be a stand-alone statement of the potential impact of this work. As with the Synopsis, the Impact section must include text only, without equations or images, and be without references or citations to items described in the full abstract.

• Impact: State how the results might affect other scientists/clinicians/patients. What new questions might now be investigated? What can be done that was not possible before and why does it matter? Try to avoid vague statements and focus on specific potential impact of the results.

Keep in mind that “impact” can take many forms; it can be, for example, that other scientists might now think about a problem differently, opening new questions or lines of investigations to be answered; it can be specific applications of the advances in technological capabilities; or new clinical information that can be disseminated and implemented more widely.

The impact of your study might affect several people, or several million people, both scenarios being important. The question is, what will be different because of the results of your study? Who will care (other than the next post-doc in the lab), and why? Your results do not need to “change the world”, although small changes together do change the world!  Beware the positive impact bias! Impact does not mean that something had a positive or expected result. “Why the work will matter” might be that it shows that a pivot or new direction is needed.

Please view examples of Synopsis and Impact here.

Digital Poster “Teaser” Previews and Thumbnail Images

Presentations will be highlighted using a single figure and information about the authors in an abstract thumbnail. In order to accomplish this, you will be asked for the following:

1. A Preview Figure (thumbnail) for use on program session pages and on preview/teaser pages. It is not part of the abstract review. This figure:
   • Should be a simple & uncluttered representation of your work.
   • Does not have a caption, nor should it have small text within the image.
   • Is legible at small sizes, especially on mobile devices.
   • Will be visible to the public on session pages.
2. The Impact statement that accompanies the synopsis, described above.
3. An institutional logo image file. If you need to acknowledge more than one institution, you must create a single image containing all necessary logos. Alternatively, you may use a project- or consortium logo instead of institutional logos.

Suggested Abstract Format

We recommend including the following sections, although we also note that there are often good reasons to deviate from this format. In each section, answer the question listed below (do not repeat the actual question in the body of your abstract).

• INTRODUCTION: “Why was this study/research performed? What unsolved problem are you addressing?”
• METHODS: “How did you study this problem?”
• RESULTS: “Report the data, analyses and/or outcomes”
• DISCUSSION: “How do you interpret the results?”
• CONCLUSION: “What is the relevance to clinical practice or future research?”
• REFERENCES: References should use the suggested style below.

Figures

• Up to 5 Figures should be uploaded as part of the abstract, along with a caption for each figure.
• Additionally, one Preview Figure should be uploaded (as described above, with no caption).

Word Limits

The following word limits will apply:

• Title: 125 characters
• Synopsis: 100 words (combined 4 sections)
• Impact: 40 words
• Body of the Abstract: 750 words (references not included)
• Preview Figure: 1 figure, no caption, legible at the width of a mobile smartphone
• Figures: up to 5 only for abstract
• Figure Captions: 500 characters per caption

References

Cite each source in numerical order using superscript Arabic numerals.

• Example 1:
  A review of regulations has been complete by the WHO¹⁵.
• Example 2:
  The data were as follows ^3,4:
• Example 3:
  …methods for MR fingerprinting ^11-14,25,

At the end of the abstract, list references numerically in the order in which they were cited in the text.

• Example 1:
  1. Rainier S, Thomas D, Tokarz D, et al. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch Neurol. 2004;61(7):1025‐1029.
• Example 2:
  2. World Health Organization. Injury: A Leading Cause of the Global Burden of Disease, 2000. Geneva, Switzerland: World Health Organization; 2002.
• Example 3:
  3. Weiss R. The promise of precision prescriptions. Washington Post. June 24, 2000:A1. http://www.washingtonpost.com. Accessed October 10, 2001.

Further Information

Abstract Content Guidelines

• Bias: The content may not promote the proprietary interests of any commercial entity. Evident bias in favor of a particular product or company is grounds for rejection. (Reference to the use of a particular company’s products or equipment does not represent bias. Non-data-driven statements of superiority, however, would be considered biased.)
• Content must be restricted to scientific, engineering, and clinical studies, as well as industry issues and operation of devices. Product/company names should be included only to identify the MR hardware/software/peripherals used but not to promote proprietary interests (see first bullet point).
• Abstracts must be written in English.
• All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for the recommendations as indications or contraindications in the care of patients.
• All scientific research referred to, reported, or used in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
• Abstracts previously submitted to the ISMRM or to another society/journal, but not accepted, may be resubmitted.
• While aids such as ChatGPT or similar may be used to help in writing, authors of the abstracts bear complete responsibility for the accuracy of all data, analysis, and statements within abstracts. Non-human tools should not be listed as authors. Falsification of data or statements is unacceptable, and is grounds for rejection of current and future submissions to ISMRM.

Abstract Review Criteria

• Adherence to the Abstract Content Guidelines (as stated above).
• Duplication of Content (see also above). Multiple submissions of the same or nearly the same abstract is grounds for rejection of all submitted abstracts.
• Prior Publication. Content should differ substantially from any publication with publication date (or early view) prior to the abstract deadline.
• Innovation/novelty: advancement of knowledge, and/or improvement of capabilities.
• Quality: The results should be substantive and not just implied. Where appropriate:
  • Comprehensive statistical analysis should be applied.
  • Images and spectra should be of the highest quality.
• Impact: The method or data in the abstract should aim to advance or change the field in significant ways. Incremental changes are less likely to be accepted for presentation.

Tips for Authors

• Write a draft of the Synopsis and Impact first!
• Contact all co-authors prior to submission. It is considered unethical to submit abstracts listing co-authors who have not agreed to the submission. In general, co-authors will expect to read and approve of the content of an abstract, but at a minimum they should be aware of the submission and consent to being listed as an author.

Publication of Abstracts

The Proceedings will be published electronically only. The full text of all accepted abstracts will be available online two weeks before the meeting to pre-registered attendees only (19 April 2024). If you wish to have access to the Proceedings before the meeting, you must pre-register.

All submitted abstracts are treated as confidential from the time of submission to the publication date of 19 April 2024.

All copyrights to accepted abstracts become the property of ISMRM. No proprietary information may be withheld by authors.